Catalysts for $BTAI
7 tracked
Apr 16, 2026
drug shortage
Dexmedetomidine Hydrochloride Injection shortage — Par Health, USA LLC
BioXcel Therapeutics, Inc.
→
Mar 26, 2026
earnings
BioXcel Therapeutics, Inc. earnings
BioXcel Therapeutics, Inc.
→
Feb 25, 2026
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
BioXcel Therapeutics, Inc.
→
Nov 19, 2025
approval
IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE) — FDA approval
dexmedetomidine
→
Apr 30, 2025
recall
Denver Solutions, LLC DBA Leiters Health recall (Cls II)
BioXcel Therapeutics, Inc.
→
Oct 24, 2022
approval
IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE) — FDA approval
dexmedetomidine
→
Apr 5, 2022
approval
IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE) — FDA approval
dexmedetomidine
→